{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:30:43Z","timestamp":1794537043453,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Pneumocystis jirovecii (P. jirovecii)<\/jats:italic> is an opportunistic fungus responsible for <jats:italic>Pneumocystis<\/jats:italic> pneumonia (PCP) in deeply immunocompromised patients and for pulmonary colonization in individuals with mild immunosuppression or impaired respiratory function. PCP and Cytomegalovirus (CMV) co-infections have been widely described whereas those involving other Herpesviruses (HVs) such as Epstein-Barr virus (EBV), Herpes simplex virus type 1 and type 2 (HSV-1 and \u2009-2), and Varicella zoster virus (VZV) remain scarce. To date, no data are available concerning HVs co-infections in <jats:italic>P. jirovecii<\/jats:italic> colonization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Our main objective was to evaluate the frequency of HVs in bronchoalveolar lavage fluid (BALF) samples from patients with PCP or with pulmonary colonization. The secondary objective was to assess the relationship between HVs and the mortality rate in PCP patients. A retrospective single-center study over a seven-year period was conducted. All patients with <jats:italic>P. jirovecii<\/jats:italic> detected using PCR in a BALF sample and for whom a PCR assay for HVs detection was performed were included in the study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred and twenty-five patients were included, corresponding to 77 patients with PCP and 48 colonized patients. At least one HV was detected in 54\/77 (70.1%) PCP patients and in 28\/48 (58.3%) colonized patients. EBV was the most frequent in both groups. Furthermore, the 30-day survival rate in PCP patients was significantly lower with [EBV\u2009+\u2009CMV] co-infection than that with EBV co-infection, [EBV\u2009+\u2009HSV-1] co-infection and without HV co-infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results show that the frequency of HV, alone or in combination is similar in PCP and colonization. They also suggest that [EBV\u2009+\u2009CMV] detection in BALF samples from PCP patients is associated with an increased mortality rate, underlying the significance to detect HVs in the course of PCP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12941-023-00663-2","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:45:43Z","timestamp":1705797943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pulmonary co-infections by Pneumocystis jirovecii and Herpesviridae: a seven-year retrospective study"],"prefix":"10.1186","volume":"23","author":[{"given":"Alan","family":"Rucar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Totet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Le Govic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Demey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,20]]},"reference":[{"key":"663_CR1","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.tim.2020.03.006","volume":"28","author":"G Nevez","year":"2020","unstructured":"Nevez G, Hauser PM, Le Gal S. Pneumocystis Jirovecii. Trends Microbiol. 2020;28:1034\u20135. https:\/\/doi.org\/10.1016\/j.tim.2020.03.006.","journal-title":"Trends Microbiol"},{"key":"663_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/339548","volume":"34","author":"KA Sepkowitz","year":"2002","unstructured":"Sepkowitz KA. Opportunistic Infections in patients with and patients without acquired Immunodeficiency Syndrome. Clin Infect Dis. 2002;34:1098\u2013107. https:\/\/doi.org\/10.1086\/339548.","journal-title":"Clin Infect Dis"},{"key":"663_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/cid\/ciaa1805","volume":"72","author":"K Lagrou","year":"2021","unstructured":"Lagrou K, Chen S, Masur H, Viscoli C, Decker CF, Pagano L, et al. Pneumocystis Jirovecii Disease: basis for the revised EORTC\/MSGERC invasive fungal Disease definitions in individuals without human immunodeficiency virus. Clin Infect Dis. 2021;72:114\u201320. https:\/\/doi.org\/10.1093\/cid\/ciaa1805.","journal-title":"Clin Infect Dis"},{"key":"663_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/CMR.00013-12","volume":"25","author":"A Morris","year":"2012","unstructured":"Morris A, Norris KA. Colonization by Pneumocystis Jirovecii and its role in Disease. Clin Microbiol Rev. 2012;25:297\u2013317. https:\/\/doi.org\/10.1128\/CMR.00013-12.","journal-title":"Clin Microbiol Rev"},{"key":"663_CR5","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1007\/s00134-008-1231-4","volume":"34","author":"CFM Linssen","year":"2008","unstructured":"Linssen CFM, Jacobs JA, Stelma FF, van Mook WNKA, Terporten P, Vink C, et al. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med. 2008;34:2202\u20139. https:\/\/doi.org\/10.1007\/s00134-008-1231-4.","journal-title":"Intensive Care Med"},{"key":"663_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","volume":"46","author":"E Azoulay","year":"2020","unstructured":"Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, et al. Diagnosis of severe Respiratory Infections in immunocompromised patients. Intensive Care Med. 2020;46:298\u2013314. https:\/\/doi.org\/10.1007\/s00134-019-05906-5.","journal-title":"Intensive Care Med"},{"key":"663_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s15010-010-0024-1","volume":"38","author":"M Vetter","year":"2010","unstructured":"Vetter M, Battegay M, Trendelenburg M. Primary cytomegalovirus Infection with accompanying Pneumocystis Jirovecii Pneumonia in a patient with large-vessel vasculitis. Infection. 2010;38:331\u20134. https:\/\/doi.org\/10.1007\/s15010-010-0024-1.","journal-title":"Infection"},{"key":"663_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/1348-0421.12778","volume":"64","author":"S Lee","year":"2020","unstructured":"Lee S, Park Y, Kim SG, Ko EJ, Chung BH, Yang CW. The impact of cytomegalovirus Infection on clinical severity and outcomes in kidney transplant recipients with pneumocystis jirovecii Pneumonia. Microbiol Immunol. 2020;64:356\u201365. https:\/\/doi.org\/10.1111\/1348-0421.12778.","journal-title":"Microbiol Immunol"},{"key":"663_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1471-2466-14-182","volume":"14","author":"C-W Chou","year":"2014","unstructured":"Chou C-W, Lin F-C, Tsai H-C, Chang S-C. The impact of concomitant pulmonary Infection on immune dysregulation in Pneumocystis Jirovecii Pneumonia. BMC Pulm Med. 2014;14:182. https:\/\/doi.org\/10.1186\/1471-2466-14-182.","journal-title":"BMC Pulm Med"},{"key":"663_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12879-017-2492-8","volume":"17","author":"Q Yu","year":"2017","unstructured":"Yu Q, Jia P, Su L, Zhao H, Que C. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii Pneumonia and pulmonary CMV co-infection: a retrospective cohort study. BMC Infect Dis. 2017;17:392. https:\/\/doi.org\/10.1186\/s12879-017-2492-8.","journal-title":"BMC Infect Dis"},{"key":"663_CR11","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1111\/crj.12961","volume":"12","author":"P Korkmaz Ekren","year":"2018","unstructured":"Korkmaz Ekren P, T\u00f6reyin ZN, Nahid P, Doskaya M, Caner A, Turgay N, et al. The association between Cytomegalovirus co-infection with Pneumocystis Pneumonia and mortality in immunocompromised non-HIV patients. Clin Respir J. 2018;12:2590\u20137. https:\/\/doi.org\/10.1111\/crj.12961.","journal-title":"Clin Respir J"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/cid\/ciy682","volume":"68","author":"SM Hosseini-Moghaddam","year":"2019","unstructured":"Hosseini-Moghaddam SM, Shokoohi M, Singh G, Dufresne SF, Boucher A, Jevnikar A, et al. A Multicenter Case-control study of the Effect of Acute rejection and cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant recipients. Clin Infect Dis. 2019;68:1320\u20136. https:\/\/doi.org\/10.1093\/cid\/ciy682.","journal-title":"Clin Infect Dis"},{"key":"663_CR13","doi-asserted-by":"publisher","first-page":"653294","DOI":"10.3389\/fmed.2021.653294","volume":"8","author":"Y Xie","year":"2021","unstructured":"Xie Y, Ruan B, Jin L, Zhu B. Case Report: next-generation sequencing in diagnosis of Pneumonia due to Pneumocystis Jirovecii and Cytomegalovirus in a patient with HIV Infection. Front Med (Lausanne). 2021;8:653294. https:\/\/doi.org\/10.3389\/fmed.2021.653294.","journal-title":"Front Med (Lausanne)"},{"key":"663_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10096-012-1730-7","volume":"32","author":"P Fillatre","year":"2013","unstructured":"Fillatre P, Chevrier S, Revest M, Gacouin A, Jouneau S, Leroy H, et al. Human herpes virus co-infection is associated with mortality in HIV-negative patients with pneumocystis jirovecii Pneumonia. Eur J Clin Microbiol Infect Dis. 2013;32:189\u201394. https:\/\/doi.org\/10.1007\/s10096-012-1730-7.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"663_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1186\/s12879-019-4715-7","volume":"19","author":"H Muramatsu","year":"2019","unstructured":"Muramatsu H, Kuriyama A, Anzai Y, Ikegami T. A co-infection of varicella-zoster virus and pneumocystis jirovecii in a non-HIV immunocompromised patient: a case report. BMC Infect Dis. 2019;19:1092. https:\/\/doi.org\/10.1186\/s12879-019-4715-7.","journal-title":"BMC Infect Dis"},{"key":"663_CR16","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1128\/JCM.01554-13","volume":"51","author":"C Damiani","year":"2013","unstructured":"Damiani C, Le Gal S, Da Costa C, Virmaux M, Nevez G, Totet A. Combined quantification of pulmonary pneumocystis jirovecii DNA and serum (1->3)-\u03b2-D-glucan for differential diagnosis of Pneumocystis Pneumonia and pneumocystis colonization. J Clin Microbiol. 2013;51:3380\u20138. https:\/\/doi.org\/10.1128\/JCM.01554-13.","journal-title":"J Clin Microbiol"},{"key":"663_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/QCO.0000000000000502","volume":"31","author":"MK Yong","year":"2018","unstructured":"Yong MK, Slavin MA, Kontoyiannis DP. Invasive fungal Disease and cytomegalovirus Infection: is there an association? Curr Opin Infect Dis. 2018;31:481\u20139. https:\/\/doi.org\/10.1097\/QCO.0000000000000502.","journal-title":"Curr Opin Infect Dis"},{"key":"663_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.300.4.413","volume":"300","author":"AP Limaye","year":"2008","unstructured":"Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413\u201322. https:\/\/doi.org\/10.1001\/jama.300.4.413.","journal-title":"JAMA"},{"key":"663_CR19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/infdis\/jiab460","volume":"225","author":"R L\u00e9cuyer","year":"2022","unstructured":"L\u00e9cuyer R, Issa N, Tessoulin B, Lavergne R-A, Morio F, Gabriel F, et al. Epidemiology and clinical impact of respiratory coinfections at diagnosis of Pneumocystis Jirovecii Pneumonia. J Infect Dis. 2022;225:868\u201380. https:\/\/doi.org\/10.1093\/infdis\/jiab460.","journal-title":"J Infect Dis"},{"key":"663_CR20","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1378\/chest.97.5.1072","volume":"97","author":"PR Miles","year":"1990","unstructured":"Miles PR, Baughman RP, Linnemann CC. Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS. Chest. 1990;97:1072\u20136. https:\/\/doi.org\/10.1378\/chest.97.5.1072.","journal-title":"Chest"},{"key":"663_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1164\/ajrccm\/144.1.6","volume":"144","author":"MA Jacobson","year":"1991","unstructured":"Jacobson MA, Mills J, Rush J, Peiperl L, Seru V, Mohanty PK, et al. Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii Pneumonia unaffected by concomitant pulmonary cytomegalovirus Infection. Am Rev Respir Dis. 1991;144:6\u20139. https:\/\/doi.org\/10.1164\/ajrccm\/144.1.6.","journal-title":"Am Rev Respir Dis"},{"key":"663_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/infdis\/165.1.93","volume":"165","author":"SA Bozzette","year":"1992","unstructured":"Bozzette SA, Arcia J, Bartok AE, McGlynn LM, McCutchan JA, Richman DD, et al. Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical Pneumonia in advanced human immunodeficiency virus Disease. J Infect Dis. 1992;165:93\u20138. https:\/\/doi.org\/10.1093\/infdis\/165.1.93.","journal-title":"J Infect Dis"},{"key":"663_CR23","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3109\/00365548.2011.652665","volume":"44","author":"T Kim","year":"2012","unstructured":"Kim T, Moon SM, Sung H, Kim M-N, Kim S-H, Choi S-H, et al. Outcomes of non-HIV-infected patients with Pneumocystis Pneumonia and concomitant pulmonary cytomegalovirus Infection. Scand J Infect Dis. 2012;44:670\u20137. https:\/\/doi.org\/10.3109\/00365548.2011.652665.","journal-title":"Scand J Infect Dis"},{"key":"663_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1378\/chest.119.3.844","volume":"119","author":"TL Benfield","year":"2001","unstructured":"Benfield TL, Helweg-Larsen J, Bang D, Junge J, Lundgren JD. Prognostic markers of short-term mortality in AIDS-associated pneumocystis carinii Pneumonia. Chest. 2001;119:844\u201351. https:\/\/doi.org\/10.1378\/chest.119.3.844.","journal-title":"Chest"},{"key":"663_CR25","doi-asserted-by":"publisher","first-page":"860644","DOI":"10.3389\/fmed.2022.860644","volume":"9","author":"J Zou","year":"2022","unstructured":"Zou J, Qiu T, Zhou J, Wang T, Ma X, Jin Z, et al. Clinical manifestations and outcomes of renal transplantation patients with pneumocystis jirovecii Pneumonia and cytomegalovirus co-infection. Front Med (Lausanne). 2022;9:860644. https:\/\/doi.org\/10.3389\/fmed.2022.860644.","journal-title":"Front Med (Lausanne)"},{"key":"663_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jcrc.2014.10.002","volume":"30","author":"FG Frantzeskaki","year":"2015","unstructured":"Frantzeskaki FG, Karampi E-S, Kottaridi C, Alepaki M, Routsi C, Tzanela M, et al. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers. J Crit Care. 2015;30:276\u201381. https:\/\/doi.org\/10.1016\/j.jcrc.2014.10.002.","journal-title":"J Crit Care"},{"key":"663_CR27","doi-asserted-by":"publisher","first-page":"863399","DOI":"10.3389\/fcimb.2022.863399","volume":"12","author":"L Pan","year":"2022","unstructured":"Pan L, Wu F, Cai Q, Xu Z, Hu H, Tang T, et al. Whole genome profiling of Lung Microbiome in Solid Organ Transplant recipients reveals Virus involved Microecology May Worsen Prognosis. Front Cell Infect Microbiol. 2022;12:863399. https:\/\/doi.org\/10.3389\/fcimb.2022.863399.","journal-title":"Front Cell Infect Microbiol"},{"key":"663_CR28","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1097\/CCM.0b013e31819ffea6","volume":"37","author":"L Chiche","year":"2009","unstructured":"Chiche L, Forel J-M, Roch A, Guervilly C, Pauly V, Allardet-Servent J, et al. Active cytomegalovirus Infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med. 2009;37:1850\u20137. https:\/\/doi.org\/10.1097\/CCM.0b013e31819ffea6.","journal-title":"Crit Care Med"},{"key":"663_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12890-019-1022-4","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Han Y, Feng J. Metagenomic next-generation sequencing for mixed pulmonary Infection diagnosis. BMC Pulm Med. 2019;19:252. https:\/\/doi.org\/10.1186\/s12890-019-1022-4.","journal-title":"BMC Pulm Med"},{"key":"663_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/cid\/ciz332","volume":"70","author":"G Maartens","year":"2020","unstructured":"Maartens G, Griesel R, Dube F, Nicol M, Mendelson M. Etiology of Pulmonary Infections in Human Immunodeficiency Virus-infected inpatients using Sputum Multiplex Real-time polymerase chain reaction. Clin Infect Dis. 2020;70:1147\u201352. https:\/\/doi.org\/10.1093\/cid\/ciz332.","journal-title":"Clin Infect Dis"},{"key":"663_CR31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s10096-019-03579-y","volume":"38","author":"D Steensels","year":"2019","unstructured":"Steensels D, Reynders M, Descheemaeker P, Curran MD, Hites M, Etienne I, et al. Epidemiology and clinical impact of viral, atypical, and fungal respiratory pathogens in symptomatic immunocompromised patients: a two-center study using a multi-parameter customized respiratory Taqman\u00ae array card. Eur J Clin Microbiol Infect Dis. 2019;38:1507\u201314. https:\/\/doi.org\/10.1007\/s10096-019-03579-y.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"663_CR32","doi-asserted-by":"publisher","unstructured":"Lyu J, Deng Q, Li R, Tian B, Zhao Y, Hu X et al. Pneumonia caused by Coinfection with Cytomegalovirus and Pneumocystis Jirovecii in an HIV-Negative infant diagnosed by Metagenomic Next-Generation sequencing. IDR 2022;Volume 15:3417\u201325. https:\/\/doi.org\/10.2147\/IDR.S364241.","DOI":"10.2147\/IDR.S364241"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00663-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00663-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00663-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:46:39Z","timestamp":1705797999000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00663-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00663-2","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,20]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted using anonymous health care data in accordance with the French law and after approval from the local ethics committee (Direction de la Recherche Clinique et de l\u2019Innovation, Amiens-Picardy University Hospital, Ref. PI2022_843_0011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}